Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats
1999

Effective Isolated Limb Perfusion in Rats

publication Evidence: moderate

Author Information

Author(s): Wilt J H W de, Manusama E R, Tiel S T van, Ijken M G A van, Hagen T L M ten, Eggermont A M M

Primary Institution: Department of Surgical Oncology, University Hospital Rotterdam Dijkzigt – Daniel den Hoed Cancer Centre

Hypothesis

What are the prerequisites for effective isolated limb perfusion using TNF and melphalan in rats?

Conclusion

The combination of TNF and melphalan shows strong synergistic anti-tumour effects, with specific conditions needed for optimal results.

Supporting Evidence

  • The combination of 50 μg TNF and 40 μg melphalan led to a 71% response rate.
  • Hypoxia enhanced the anti-tumour activity of melphalan and TNF alone but not their combination.
  • Shorter perfusion times decreased anti-tumour responses.
  • Higher temperatures (38–39°C or 42–43°C) resulted in better response rates, but too high a temperature caused local toxicity.

Takeaway

This study found that a special treatment using two drugs can help fight tumors in rats, but it needs to be done in a certain way to work best.

Methodology

An isolated limb perfusion model was used to study the effects of TNF and melphalan on soft tissue sarcoma-bearing rats.

Participant Demographics

Rats with soft tissue sarcoma.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690335

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication